JP2022547080A - 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法 - Google Patents

超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法 Download PDF

Info

Publication number
JP2022547080A
JP2022547080A JP2022514679A JP2022514679A JP2022547080A JP 2022547080 A JP2022547080 A JP 2022547080A JP 2022514679 A JP2022514679 A JP 2022514679A JP 2022514679 A JP2022514679 A JP 2022514679A JP 2022547080 A JP2022547080 A JP 2022547080A
Authority
JP
Japan
Prior art keywords
elv
vlc
carbon
cells
erovanoids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022514679A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022547080A5 (enExample
Inventor
リカルド パラシオス ペレーズ
ニコラス ジー． バザン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2022547080A publication Critical patent/JP2022547080A/ja
Publication of JP2022547080A5 publication Critical patent/JP2022547080A5/ja
Priority to JP2025111395A priority Critical patent/JP2025143368A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2022514679A 2019-09-04 2020-09-04 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法 Pending JP2022547080A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025111395A JP2025143368A (ja) 2019-09-04 2025-07-01 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962895737P 2019-09-04 2019-09-04
US62/895,737 2019-09-04
US201962923770P 2019-10-21 2019-10-21
US62/923,770 2019-10-21
US201962924359P 2019-10-22 2019-10-22
US62/924,359 2019-10-22
US202062964995P 2020-01-23 2020-01-23
US62/964,995 2020-01-23
PCT/US2020/049541 WO2021046448A1 (en) 2019-09-04 2020-09-04 Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025111395A Division JP2025143368A (ja) 2019-09-04 2025-07-01 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法

Publications (2)

Publication Number Publication Date
JP2022547080A true JP2022547080A (ja) 2022-11-10
JP2022547080A5 JP2022547080A5 (enExample) 2024-04-02

Family

ID=74853054

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022514679A Pending JP2022547080A (ja) 2019-09-04 2020-09-04 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法
JP2025111395A Pending JP2025143368A (ja) 2019-09-04 2025-07-01 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025111395A Pending JP2025143368A (ja) 2019-09-04 2025-07-01 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法

Country Status (9)

Country Link
US (1) US20220339134A1 (enExample)
EP (1) EP4025201A4 (enExample)
JP (2) JP2022547080A (enExample)
CN (1) CN114650814A (enExample)
AU (1) AU2020343029A1 (enExample)
BR (1) BR112022003985A2 (enExample)
CA (1) CA3153088A1 (enExample)
MX (1) MX2022002687A (enExample)
WO (1) WO2021046448A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022056311A1 (en) * 2020-09-10 2022-03-17 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use
CN118524834A (zh) * 2021-12-03 2024-08-20 株式会社日水 氧化应激缓和方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018175288A1 (en) * 2017-03-20 2018-09-27 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010037180A1 (en) * 2008-10-03 2010-04-08 Glycan Biosciences Pty Ltd Anionic oligosaccharide conjugates
US20130190399A1 (en) * 2009-10-31 2013-07-25 Martek Biosciences Corporation Synthesis and use of omega-3 and omega 6 very long chain polyunsaturated fatty acids (VLC-PUFA)
WO2016130522A1 (en) * 2015-02-09 2016-08-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases
US20170014365A1 (en) * 2015-07-14 2017-01-19 The Board Of Regents Of The University Of Oklahoma Compositions Containing Very Long Chain Saturated Fatty Acids and Methods of Use
WO2017077528A2 (en) * 2015-11-02 2017-05-11 Salzman Lovelace Investments, Ltd. Methods and pharmaceutical compositions for treatment of lung inflammation
US20220226270A1 (en) * 2019-04-04 2022-07-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018175288A1 (en) * 2017-03-20 2018-09-27 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
黒田悦史他: "「微細粒子による免疫系の活性化とアレルギー性炎症」", 日衛誌(JPN. J. HYG.), vol. 72, JPN6024030038, 2017, pages 27 - 31, ISSN: 0005539558 *

Also Published As

Publication number Publication date
JP2025143368A (ja) 2025-10-01
MX2022002687A (es) 2022-06-16
CN114650814A (zh) 2022-06-21
EP4025201A4 (en) 2023-08-30
BR112022003985A2 (pt) 2022-05-24
EP4025201A1 (en) 2022-07-13
US20220339134A1 (en) 2022-10-27
CA3153088A1 (en) 2021-03-11
WO2021046448A1 (en) 2021-03-11
AU2020343029A1 (en) 2022-03-31

Similar Documents

Publication Publication Date Title
JP2025143368A (ja) 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法
CA3000985C (en) Method for treating neurodegenerative diseases
JP2019511495A (ja) ＧＳＫ３β阻害薬チデグルシブによるＣＤＫＬ５障害の治療
WO2013070879A1 (en) Methods for treating spinal cord injury with lpa receptor antagonists
EP3253387A1 (en) Compounds and uses in treatment of senescence-associated conditons
JP2020514391A (ja) 超長鎖多価不飽和脂肪酸、エロバノイドヒドロキシル化誘導体、および使用方法
US9956202B2 (en) Use of indolyl and indolinyl hydroxamates for treating neurodegenerative disorders or cognitive decicits
Park et al. Suppressive effects of britanin, a sesquiterpene compound isolated from Inulae flos, on mast cell-mediated inflammatory responses
JP7850416B2 (ja) 細胞外小胞に含まれるｅｎａｍｐｔの産生および使用
WO2017135753A1 (ko) 혈관내피성장인자를 과발현한 줄기세포를 유효성분으로 포함하는 퇴행성 신경질환의 예방 또는 치료용 약학적 조성물
JP2017128578A (ja) 腎疾患の治療におけるモノおよびジカルボン酸のアミドの使用
AU2021283886A1 (en) Dihomo-gamma linolenic acid (DGLA) is a novel senolytic
US20240075004A1 (en) Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use
JP6928450B2 (ja) エンドセリンｂ受容体アゴニストを用いた、神経精神疾患を治療するための組成物及び方法
AU2025220850A1 (en) Compositions for regulating homeostasis of cortisol and improving sleep quality and methods of use and production thereof
US9950036B2 (en) Treatment of mood and stress related disorders
JP5788907B2 (ja) 疾患の治療に使用される化合物
JP2019530741A (ja) 神経保護及び神経疾患におけるｃｇｒｐ受容体アンタゴニストの使用
US11925642B2 (en) Regulation of eIF4E activity for migraine therapy
JP2023541886A (ja) 超長鎖多価不飽和脂肪酸、エロバノイドヒドロキシル化誘導体、及び使用方法
US20240390377A1 (en) Composition for the prevention or treatment of neurodegenerative or motor neuron diseases comprising halofuginone as an active ingredient
KR101478304B1 (ko) 신경염증 질환의 예방 또는 치료용 약학 조성물
CN118593706A (zh) 通过调节Endoglin治疗痴呆的方法
WO2022217035A1 (en) Activators of integrated stress response pathway for protection against ferroptosis
JP7249433B2 (ja) 蜂毒抽出物を有効成分として含有する神経炎症疾患の予防または治療用組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220601

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220907

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230720

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230901

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240319

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240801

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241030

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250303